Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Reata Pharmaceuticals
Reata Pharmaceuticals
Reata gets another shot in Friedreich’s ataxia
Reata gets another shot in Friedreich’s ataxia
EP Vantage
Reata Pharmaceuticals
omaveloxolone
Friedreich's Ataxia
Flag link:
The Week Ahead In Biotech: Pending Clinical Readouts In Focus
The Week Ahead In Biotech: Pending Clinical Readouts In Focus
Yahoo/Benzinga
Retrophin
Karyopharm
Celyad
uniQure
Sangamo Therapeutics
Catalyst Biosciences
Novo Nordisk
Reata Pharmaceuticals
Vertex Pharmaceuticals
Bellicum
Gilead Sciences
Jaguar Health
TRACON Pharmaceuticals
FibroGen
Aslan Pharma
ObsEva
Sorrento Therapeutics
Flag link:
Reata Pharmaceuticals gets orphan drug designation for bardoxolone methyl to treat ADPKD
Reata Pharmaceuticals gets orphan drug designation for bardoxolone methyl to treat ADPKD
Pharmaceutical Business Review
Reata Pharmaceuticals
ADPKD
autosomal dominant polycystic kidney disease
Bardoxolone
orphan drugs
FDA
Flag link:
Reata stock surges on positive data in CKD patients
Reata stock surges on positive data in CKD patients
Biopharma Dive
Reata Pharmaceuticals
chronic kidney disease
Bardoxolone
Flag link:
Reata buoyed by positive data for kidney disease drug
Reata buoyed by positive data for kidney disease drug
BioPharma Dive
Reata Pharmaceuticals
kidney disease
bardoxolone methyl
Flag link:
5 Biotech IPOs Lead The Way In 2016
5 Biotech IPOs Lead The Way In 2016
Seeking Alpha
biotech
IPOs
AveXis
Clearside Biomedical
Protagonist Therapeutics
Reata Pharmaceuticals
Bluebird Bio
Flag link:
Despite sluggish IPO market, biotechs continue to lead the way
Despite sluggish IPO market, biotechs continue to lead the way
BioPharma Dive
IPOs
biotech
Reata Pharmaceuticals
Syros Pharmaceuticals
Flag link:
Biotechs launch an IPO blitz as Nasdaq stumbles out of the gate
Biotechs launch an IPO blitz as Nasdaq stumbles out of the gate
Fierce Biotech
biotech
IPOs
Editas Medicine
Syndax Pharma
Audentes Therapeutics
Bavarian Nordic
Corvus Pharmaceuticals
Reata Pharmaceuticals
Flag link:
Abbott Labs Shares Slide on Kidney Study
Abbott Labs Shares Slide on Kidney Study
PharmPro
Abbott Laboratories
Bardoxolone
Reata Pharmaceuticals
Flag link:
Pages
« first
‹ previous
1
2